By Bobbie Katz, CRWENewswire Correspondent
It's The "Talk" of The Town
Neural Communicator has developed brain/computer interface devices and software designed to enable people with extreme disabilities to communicate. Being an innovative software development company, HealthMed Services LTD (OTCPK:HEME) has announced that it has entered into final negotiations to acquire all rights, title, and interest to Neural Communicator software and hardware.
HealthMed President/CFO John Popovic commented, "We are extremely keen on completing the acquisition of Neural Communicator. The product will bring easy communication capability to those currently unable to communicate as well as expanding the communication ability of others with disabilities restricting their communication capacity. Acquiring this leading edge technology expands HealthMed's product lineup and will position us strongly in the marketplace."
Neural Communicator is intended for people disabled in such a way that they cannot communicate by speech or by using their body. Biofeedback is used for computer input and controlling the application features.
For More Information On HealthMed’s "Talk" of The Town Visit: http://www.healthmedltd.com
Crown Equity Holdings Inc. (OTCBB:CRWE) has added a company known as PenStox.com, a German Small Cap Service Provider led by Lars Schmidt, to its CRWENewswire.com team. PenStox.com moderates the German CRWEnewswire websites in Germany and adds content to the CRWENewswire website.
Crown Equity Holdings plans to add more European companies to its CRWEnewswire network. The French site is being finalized, and is on line now at www.crwenewswire.fr. Additional sites in work are for Mexico, Taiwan and India.
Crown Equity Holdings is currently in the process of expanding its in-house IT infrastructure. Although their current web page load time is better than 75% of other internet websites, when completed, the modifications will raise this load time to better then 90% of other internet websites while increasing website visitor capacity by 400%. As CRWE adds more countries' webswites to it's domain, this addition of new servers and IT personnel is of great benefit.
Crown Equity Holdings Inc . is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused its primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients.
Please visit Crown Equity Holdings Inc's website at: www.crownequityholdings.com
St. Jude Medical, Inc. (NYSE:STJ) applauds the updated class and level of evidence for Fractional Flow Reserve (NYSEARCA:FFR)-guided treatment in the Guidelines on Percutaneous Coronary Intervention (NYSE:PCI) announced Monday at the European Society of Cardiology (NYSE:ESC) congress in Stockholm. Supporting this change are the very strong one and two year data from the landmark FAME (Fractional Flow Reserve (FFR) vs. Angiography in Multivessel Evaluation) trial, which demonstrated improved outcomes for patients with multivessel coronary artery disease whose treatment was guided by St. Jude Medical FFR Measurement Systems rather than by standard angiography alone.
The ESC guidelines, which are intended to assist health care providers in clinical decision making, now classify FFR-guided treatment as “Class I, with level of evidence A.” Level of evidence A is the highest level available, requiring the most clinical evidence, and is awarded only when data has been derived from multiple randomized clinical trials or meta-analyses. Class I indicates a general agreement that a given treatment or procedure is beneficial, useful, and effective.
Fractional Flow Reserve (FFR) is an index determining the functional severity of narrowings in the coronary arteries as measured by PressureWire Certus and PressureWire Aeris. FFR specifically identifies which coronary narrowings are responsible for significantly obstructing the flow of blood to a patients’ heart muscle (called ischemia), and it is used by the interventional cardiologist to direct coronary interventions and assess results for improved treatment outcomes.
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide.
For more information, please visit www.sjm.com
The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwenewswire.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. (OTCPK:CRWE) has received five thousand dollars in cash from a third party (Media Elite Consultants LLC) for (1) day of advertising for Healthmed Services Ltd. (OTC BB: HEME.OB)